Clicky

Charles River Laboratories International, Inc.(CRL) News

Date Title
Nov 17 Chairman of Charles River Laboratories International James Foster Buys 2.3% More Shares
Nov 16 Charles River Introduces CliniPrime Cryopreserved Leukopaks, Expanding Suite of GMP-Compliant Cellular Products
Nov 13 Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
Nov 10 Charles River Laboratories International, Inc. (NYSE:CRL) Q3 2023 Earnings Call Transcript
Nov 9 Charles River Laboratories’ Industry Experts to Present Advanced Modalities at Neuroscience 2023
Nov 9 Q3 2023 Charles River Laboratories International Inc Earnings Call
Nov 8 Charles River Laboratories Posts Mixed Q3 Results; Updates 2023 Outlook
Nov 8 Charles River's (CRL) Q3 Earnings Beat, Margins Decline
Nov 8 Charles River (CRL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Nov 8 Charles River Laboratories Announces Third-Quarter 2023 Results
Nov 6 Unlocking Q3 Potential of Charles River (CRL): Exploring Wall Street Estimates for Key Metrics
Sep 12 Long-Term Returns of Billionaire Barry Rosenstein’s Activist Targets
Sep 11 Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
Sep 8 Charles River (CRL) Down 6.1% Since Last Earnings Report: Can It Rebound?
Sep 6 Steer Clear of Outrageously Valued VinFast Stock. 3 EV Stocks to Buy Instead.
Sep 6 Here's Why You Should Retain Charles River (CRL) Stock Now
Sep 6 Charles River and PathoQuest Announce Publication of a Head-to-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay as a Reliable In Vitro Alternative to Animal Testing Methods
Aug 30 Unveiling Charles River Laboratories International's Value: Is It Really Priced Right? A ...
Aug 30 Charles River Labs to shut 1 of 3 facilities in South San Francisco
May 1 Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID